Cite
HARVARD Citation
Manlay, L. et al. (2021). Comparison of short‐ and long‐term effectiveness between ustekinumab and vedolizumab in patients with Crohn's disease refractory to anti‐tumour necrosis factor therapy. Alimentary pharmacology & therapeutics. 53 (12), pp. 1289-1299. [Online].